Skip to main content

Advertisement

Table 3 Description of the 11 patients fulfilling only ACR/EULAR criteria

From: Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome

Pt. Age Dura-tiona Eyeb Mouthc ESSDAI ESSDAI domainsd Other AID Low UWSF Schirmer VB ≥ 4 SGB ANA SSA SSB RF IgG SGUS Diage
1 51 1 0 1 4 A, B 0 1 0   1 0 0 0 1 23.7 1 1
2 38 2 0 1 2 A 0 0 1   1 320 0 0 1 11.5 0 0
3 80 12 0 1 0 / Thyroiditis 1 0   1 320 0 0 0 12.1 0 1
4 54 1 0 0 5 A, G, B 0 0 0   1 1 280 1 0 0 17.5 1 1
5 19 6 0 0 10 PNS 0 0 0   1 320 1 0 1 12.5 1 1
6 61 5 1 0 2 A Thyroiditis 0 0 1 1 0 0 0 1 9.5 1 0
7 64 23 1 0 6 A, H, B AI hepatitis 0 0 0 1 320 1 0 0 15.8 / 1
8 57 4 0 1 10 A, H, B AI hepatitis 0 1 1 0 1280 1 1 1 20.8 / 1
9 67 2 0 1 2 A 0 0 1 0 1 320 0 0 0 8 0 0
10 42 1 0 0 5 A, B 0 0 0   1 320 1 0 0 19 0 1
11 56 3 0 1 4 L Thyroiditis 0 1   1 160 0 0 0 9.7 0 0
  1. Pt patient, ESSDAI EULAR pSS Disease Activity Index, AID autoimmune disease, UWSF unstimulated whole salivary flow, VB van Bijsterveld score, SGB salivary gland biopsy, ANA anti-nuclear antibodies, SSA Anti-Sjögren's-syndrome-related antigen A RF rheumatoid factors, SGUS salivary gland ultrasonography
  2. aSymptom duration in years
  3. bSubjective ocular dryness
  4. cSubjective oral dryness
  5. d A articular, P pulmonary, PNS peripheral nervous system, R renal, G glandular, C cutaneous, L lymphadenopathy, H hematological, B biological
  6. eDiagnosis of primary Sjögren’s syndrome by the physician